TGF-β and IL-10 are anti-inflammatory, which, produced by many cell types, play a crucial role in inhibiting the antitumor immune response in glioma (65–67) by activating the polarization of M0 into M1 or M2 macrophages (68–70). This evidence concerns the gene TGFB1 and central nervous system cancer.